Christian Naumann

Christian looks back on a long-standing international career with blue chip pharmaceutical corporations including Schering, Bayer, WBA and Sandoz/Novartis. In his several roles in Germany, Mexico, London and Munich, he launched Rituximab’s, Enbrel’s, Humira’s & Neulasta’s biosimilars in Europe and the US for Sandoz International, expanded and optimized WBA’s private label portfolios Almus & Alvita across Europe and into new markets, launched J&J’s/Bayer’s biggest blockbuster Xarelto® (rivaroxaban) globally and lead Bayer's portfolios in General Medicine, Women’s Healthcare and Cardiology in Europe and Canada, before advising Cannabis companies and joining Therismos.